Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / XERS - Xeris Biopharma Holdings Inc. (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript

XERS - Xeris Biopharma Holdings Inc. (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript

Xeris Pharmaceuticals Inc.
Xeris Biopharma Holdings, Inc. (XERS) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Allison Wey - SVP, IR & Corporate Communications Paul Edick - Chairman & CEO Steve Pieper - CFO Conference Call Participants David Amsellem - Piper Sandler Roanna Ruiz - SVB Securities Vamil Divan - Mizuho Securities Robin Garner - Craig-Hallum Oren Livnat - H.C. Wainwright Presentation Operator Hello, and welcome to today’s Xeris Biopharma’s First Quarter 2022 Financial Results Conference Call and Webcast. My name is Bailey and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call, with an opportunity for questions-and-answers at the end. [Operator Instructions] I would now like to pass the conference over to Allison Wey, Senior Vice President of Investor Relations and Corporate Communications. Allison, please go ahead. Allison Wey Thank you, Bailey. Good morning and welcome

For further details see:

Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Xeris Pharmaceuticals Inc.
Stock Symbol: XERS
Market: NASDAQ
Menu
XERS XERS Quote XERS Short XERS News XERS Articles XERS Message Board
Get XERS Alerts

News, Short Squeeze, Breakout and More Instantly...